Citadel Advisors
AHG

Citadel Advisors’s Akso Health Group AHG Stock Holding History

Citadel Advisors’s Portfolio AHG Stock Details AHG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-23,209
Closed -$21K – 14827
2022
Q3 		$21K Buy
+23,209
New +$24.6K ﹤0.01% 12050
2022
Q2 		– Sell
-36,856
Closed -$62K – 12782
2022
Q1 		$62K Buy
+36,856
New +$58.5K ﹤0.01% 12653
2021
Q4 		– Sell
-15,321
Closed -$34K – 13716
2021
Q3 		$34K Sell
15,321
-9,955
-39% -$16.6K ﹤0.01% 13522
2021
Q2 		$41K Sell
25,276
-3,154
-11% -$4.87K ﹤0.01% 13404
2021
Q1 		$50K Buy
+28,430
New +$64.2K ﹤0.01% 12896
2020
Q3 		– Sell
-3,544
Closed -$9K – 10010
2020
Q2 		$9K Sell
3,544
-1,091
-24% -$1.93K ﹤0.01% 9647
2020
Q1 		$6K Sell
4,635
-11,251
-71% -$17.1K ﹤0.01% 9469
2019
Q4 		$45K Sell
15,886
-3,611
-19% -$9.46K ﹤0.01% 8782
2019
Q3 		$89K Sell
19,497
-69,882
-78% -$438K ﹤0.01% 8536
2019
Q2 		$638K Buy
89,379
+23,367
+35% +$195K ﹤0.01% 6433
2019
Q1 		$661K Buy
66,012
+58,591
+790% +$508K ﹤0.01% 6314
2018
Q4 		$56K Sell
7,421
-2,019
-21% -$33.3K ﹤0.01% 8463
2018
Q3 		$223K Buy
+9,440
New +$245K ﹤0.01% 8041
2018
Q1 		– Sell
-5,568
Closed -$184K – 8216
2017
Q4 		$184K Buy
+5,568
New +$198K ﹤0.01% 7165

Other funds holding AHG

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citadel Advisors's AHG Position: Q4 2022 in Review

Citadel Advisors sold out of Akso Health Group (AHG) in Q4 2022, closing a stake of 23,209 shares — an estimated $21K sold.

Citadel Advisors first reported a position in AHG in Q4 2017 and held it in 14 quarters. The position peaked at $661K in Q1 2019. 5 funds tracked by Wall St. Rank hold AHG as of Q4 2022.

  • Citadel Advisors reported no remaining Akso Health Group position as of Q4 2022 after selling out during the quarter.
  • Citadel Advisors sold 23,209 Akso Health Group shares in Q4 2022, an estimated $21K.
  • Citadel Advisors first reported a position in Akso Health Group in Q4 2017 and held it in 14 quarters.
  • Citadel Advisors's Akso Health Group position peaked at $661K in Q1 2019.
  • 5 funds tracked by Wall St. Rank held Akso Health Group as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.